Get the Stockscreener App
85.97
1.35%
-1.18
After Hours:
86.20
0.23
+0.27%
Spdr Biotech Etf stock is traded at $85.97, with a volume of 6.26M.
It is down -1.35% in the last 24 hours and down -5.29% over the past month.
See More
Previous Close:
$87.15
Open:
$87.05
24h Volume:
6.26M
Relative Volume:
0.72
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.25%
1M Performance:
-5.29%
6M Performance:
-15.06%
1Y Performance:
-11.46%
1-Day Range:
$85.44
$88.21
1-Week Range:
$84.19
$88.44
52-Week Range:
$81.14
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
85.97 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
271.18 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
551.42 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
554.06 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
217.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
468.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Stock (XBI) Latest News
Healthcare Sector Trying To Bounce Back - Seeking Alpha
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
(XBI) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Top-rated biotechs with negative enterprise values - MSN
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Van ECK Associates Corp Makes New $1.50 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
How to Take Advantage of moves in (XBI) - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - TradingView
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
(XBI) On The My Stocks Page - Stock Traders Daily
Want To Make Money In Biotech Stocks? Check Out OSE Immunotherapeutics - Forbes
7 Best-Performing Biotech ETFs for February 2025 - NerdWallet
XBI: Diverse Holding Amid Strong Catalysts, Buy - Seeking Alpha
Janney Montgomery Scott LLC Has $7.51 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (XBI): How to Buy - The Motley Fool
(XBI) Trading Advice - Stock Traders Daily
3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - TradingView
Wealthcare Advisory Partners LLC Sells 299 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Brookstone Capital Management Trims Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
August 15th Options Now Available For SPDR Series TrustS&P Biotech ETF (XBI) - Nasdaq
'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds - Benzinga
GAMMA Investing LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Objective long/short (XBI) Report - Stock Traders Daily
XHE: 3 Healthcare ETFs for Defensive Investing - StockNews.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
Record Growth: This Year’s Biotech Stocks Shock the Market! Don’t Miss Out! - Clinique Bio
(XBI) Technical Data - Stock Traders Daily
StockWatch: Wall Street’s Leaders and Laggards of 2024 - Genetic Engineering & Biotechnology News
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Fmr LLC Has $686,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech (XBI) Shares Cross Below 200 DMA - Nasdaq
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):